Injective (INJ) is trading at $4.91, with short interest hitting its most crowded level in weeks. Low buying volume suggests little conviction for upward moves, but a potential short squeeze could test the $5.26 resistance — a level that may define the token's direction for the rest of August.
Short Sellers Pile In, But Conviction Lags
The short book for INJ has become increasingly crowded, reflecting bearish bets that the token will decline further. However, the lack of corresponding buying volume indicates that traders are not confident enough to push the price down aggressively. This standoff creates a fragile equilibrium. Without a clear catalyst, the market remains stuck in a low-volume rut.
$5.26: The Line in the Sand
According to market data, the $5.26 price point is a critical threshold. If a short squeeze materializes, INJ could rally to that level within the next seven days. The outcome of this test will likely set the tone for the token's performance throughout August. A break above $5.26 would signal renewed bullish momentum, while a failure could embolden sellers.
What a Squeeze Would Mean
A short squeeze occurs when a crowded short position forces sellers to cover, driving the price up rapidly. With INJ currently at $4.91, a move to $5.26 would represent a roughly 7% gain. Whether that happens depends on whether any catalyst — such as a positive development or a broader market shift — triggers buying pressure. For now, traders are watching the $5.26 level closely. If it breaks, the short thesis could unravel. If it holds, bears may tighten their grip.
